Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Deepa Prasad Insider Profile
4 Followers
Deepa Prasad, Director at Design Therapeutics, holds 23.81K shares in Design Therapeutics (Ticker: DSGN), holds ― shares in vTv Therapeutics (Ticker: VTVT). Most recently, Deepa Prasad Bought ― shares of Design Therapeutics on Aug 30, 2023 for an estimated value of 27.60K.
Deepa Prasad has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Deepa Prasad holds in companies
Most Profitable Insider Trade
The most profitable trade made by Deepa Prasad
Deepa Prasad's Trading History
Design Therapeutics
Aug 30, 2023
Director
Informative Buy
27.60K
$88.56K
vTv Therapeutics
―
President and CEO, Director
―
―
List of latest transactions for each holding click on a transaction to see Deepa Prasad's performance on stock
You May Also Like
Deepa Prasad insider profile FAQ
What is the percentage of profitable transactions made by Deepa Prasad?
The percentage of profitable transactions made by Deepa Prasad is ―.
What is the average return per transaction made by Deepa Prasad?
The average return per transaction made by Deepa Prasad is ―.
What stocks does Deepa Prasad hold?
Deepa Prasad holds: DSGN, VTVT stocks.
What was Deepa Prasad’s latest transaction?
Deepa Prasad latest transaction was an Informative Buy of $27.60K.
What was Deepa Prasad's most profitable transaction?
Deepa Prasad’s most profitable transaction was an Informative Buy of DSGN stock on August 30, 2023. The return on the trade was 62.90%.
What is Deepa Prasad's role in Design Therapeutics?
Deepa Prasad's role in Design Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.